Voloridge Investment Management
CYTK icon

Voloridge Investment Management’s Cytokinetics CYTK Stock Holding History

Voloridge Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,101
Closed -$692K – 1222
2024
Q3 		$692K Sell
13,101
-542,009
-98% -$30.2M ﹤0.01% 1059
2024
Q2 		$30.1M Sell
555,110
-205,209
-27% -$12.4M 0.11% 262
2024
Q1 		$53.3M Buy
+760,319
New +$58.8M 0.19% 144
2022
Q1 		– Sell
-228,799
Closed -$10.4M – 1428
2021
Q4 		$10.4M Sell
228,799
-8,002
-3% -$309K 0.06% 449
2021
Q3 		$8.46M Buy
+236,801
New +$6.97M 0.05% 486
2020
Q4 		– Sell
-64,475
Closed -$1.4M – 1367
2020
Q3 		$1.4M Sell
64,475
-80,805
-56% -$1.89M 0.01% 834
2020
Q2 		$3.42M Buy
145,280
+113,855
+362% +$2.14M 0.04% 453
2020
Q1 		$371K Buy
+31,425
New +$401K 0.01% 802
2019
Q4 		– Sell
-21,355
Closed -$243K – 1134
2019
Q3 		$243K Buy
+21,355
New +$268K ﹤0.01% 973

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Voloridge Investment Management's CYTK Position: Q4 2024 in Review

Voloridge Investment Management sold out of Cytokinetics (CYTK) in Q4 2024, closing a stake of 13,101 shares — an estimated $692K sold.

Voloridge Investment Management first reported a position in CYTK in Q3 2019 and held it in 9 quarters. The position peaked at $53.3M in Q1 2024. 346 funds tracked by Wall St. Rank hold CYTK as of Q4 2024.

  • Voloridge Investment Management reported no remaining Cytokinetics position as of Q4 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 13,101 Cytokinetics shares in Q4 2024, an estimated $692K.
  • Voloridge Investment Management first reported a position in Cytokinetics in Q3 2019 and held it in 9 quarters.
  • Voloridge Investment Management's Cytokinetics position peaked at $53.3M in Q1 2024.
  • 346 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2024.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.